On February 20, 2026, in REGENXBIO Inc. et al. v. Sarepta Therapeutics Inc., et al., No. 2024-1408, the Federal Circuit reversed a district court decision which held that claims covering a cultured host cell containing a...more
For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the very breakthroughs in software and machine learning that enable early cancer detection and...more
The rapid advancement of artificial intelligence (AI) technologies is fueling a surge in global patent filings for AI-related innovations, but differences in national patent laws and examination standards for such inventions...more